Oscar Health Inc. (OSCR) Tops Q4 EPS by 6c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Oscar Health (OSCR) rockets 22% on narrower Q4 loss and impressive 2024 guidance
February 8, 2024 4:39 AM ESTShares of Oscar Health (NYSE: OSCR) surged 22% in premarket trading Thursday after the health insurer reported a narrower-than-expected Q4 loss and issued an upbeat EBITDA guidance for 2024.
The company posted a fourth-quarter loss per share of $0.66, less than the anticipated loss of $0.72. Revenue came in at $1.43... More
